1. Home
  2. DINO vs GRFS Comparison

DINO vs GRFS Comparison

Compare DINO & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DINO
  • GRFS
  • Stock Information
  • Founded
  • DINO 1947
  • GRFS 1940
  • Country
  • DINO United States
  • GRFS Spain
  • Employees
  • DINO N/A
  • GRFS N/A
  • Industry
  • DINO Oil & Gas Production
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DINO Energy
  • GRFS Health Care
  • Exchange
  • DINO Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • DINO 6.9B
  • GRFS 6.2B
  • IPO Year
  • DINO N/A
  • GRFS 2006
  • Fundamental
  • Price
  • DINO $42.33
  • GRFS $10.78
  • Analyst Decision
  • DINO Buy
  • GRFS Hold
  • Analyst Count
  • DINO 10
  • GRFS 1
  • Target Price
  • DINO $49.78
  • GRFS $10.30
  • AVG Volume (30 Days)
  • DINO 2.6M
  • GRFS 1.3M
  • Earning Date
  • DINO 07-31-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • DINO 4.72%
  • GRFS N/A
  • EPS Growth
  • DINO N/A
  • GRFS N/A
  • EPS
  • DINO N/A
  • GRFS 0.53
  • Revenue
  • DINO $26,861,000,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • DINO N/A
  • GRFS $5.40
  • Revenue Next Year
  • DINO $1.96
  • GRFS $6.74
  • P/E Ratio
  • DINO N/A
  • GRFS $26.22
  • Revenue Growth
  • DINO N/A
  • GRFS 10.76
  • 52 Week Low
  • DINO $24.66
  • GRFS $6.19
  • 52 Week High
  • DINO $52.71
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • DINO 46.41
  • GRFS 73.01
  • Support Level
  • DINO $42.90
  • GRFS $10.59
  • Resistance Level
  • DINO $45.15
  • GRFS $11.14
  • Average True Range (ATR)
  • DINO 1.32
  • GRFS 0.31
  • MACD
  • DINO -0.42
  • GRFS 0.06
  • Stochastic Oscillator
  • DINO 4.49
  • GRFS 77.64

About DINO HF Sinclair Corporation

HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 300 distributors and 1,500 wholesale branded sites across 30 states. It also owns and operates 4,400 miles of petroleum product pipelines and terminals principally in the southwestern United States.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: